NYSE American - Delayed Quote • USD InfuSystem Holdings, Inc. (INFU) Follow Compare 7.54 -0.38 (-4.80%) At close: January 10 at 4:00:00 PM EST 7.54 0.00 (0.00%) After hours: January 10 at 4:05:02 PM EST All News Press Releases SEC Filings All SEC Filings Corporate Changes & Voting Matters Periodic Financial Reports Proxy Statements Tender Offer/Acquisition Reports Offering Registrations Sidoti Events, LLC's Virtual December Small-Cap Conference NEW YORK, NY / ACCESSWIRE / December 3, 2024 / Sidoti Events, LLC, an affiliate of Sidoti & Company, LLC, has released the presentation schedule and weblinks for its two-day December Small-Cap Conference taking place Wednesday and Thursday, December ... InfuSystem to Present at Sidoti Small Cap Conference on December 4, 2024 ROCHESTER HILLS, Mich., November 22, 2024--InfuSystem to Present at Sidoti Small Cap Conference on December 4, 2024 InfuSystem Appoints Ronald Hundzinski to the Board of Directors ROCHESTER HILLS, Mich., November 18, 2024--InfuSystem Appoints Ronald Hundzinski to the Board of Directors Q3 2024 InfuSystem Holdings Inc Earnings Call Q3 2024 InfuSystem Holdings Inc Earnings Call InfuSystems Holdings Inc (INFU) Q3 2024 Earnings Call Highlights: Record Revenue and Strategic ... InfuSystems Holdings Inc (INFU) reports record revenue and strategic partnerships, while addressing challenges in pain management and capital expenditures. InfuSystem Reports Third Quarter 2024 Financial Results ROCHESTER HILLS, Mich., November 07, 2024--InfuSystem Reports Third Quarter 2024 Financial Results InfuSystem to Report Third Quarter 2024 Financial Results on November 7, 2024 ROCHESTER HILLS, Mich., October 31, 2024--InfuSystem to Report Third Quarter 2024 Financial Results on November 7, 2024 InfuSystems Holdings Inc (INFU) Q2 2024 Earnings Call Highlights: Strong Revenue Growth and ... InfuSystems Holdings Inc (INFU) reports robust revenue growth and strategic advancements, despite challenges in equipment sales and increased net debt. These 2 ‘Strong Buy’ Medical Device Stocks Are Poised for Growth, Says Analyst Every investor hopes to uncover a growth stock, an equity poised for rapid appreciation and substantial long-term returns. The real challenge lies in spotting the right opportunities. Several research firms are now pointing to medical device companies as promising candidates. According to KPMG, the medical device industry is on a steady upward trajectory, with global annual sales expected to grow by over 5% annually, reaching close to $800 billion by 2030. BCC Research offers an even more optimi InfuSystem to Participate in Lytham Partners Fall 2024 Investor Conference on October 1, 2024 ROCHESTER HILLS, Mich., September 27, 2024--InfuSystem to Participate in Lytham Partners Fall 2024 Investor Conference on October 1, 2024 InfuSystem and Sanara MedTech Inc. Announce Exclusive United States Distribution Agreement with ChemoMouthpiece, LLC ROCHESTER HILLS, Mich., September 11, 2024--InfuSystem and Sanara MedTech Inc. Announce Exclusive United States Distribution Agreement with ChemoMouthpiece, LLC Sanara MedTech Inc. and InfuSystem Holdings, Inc. Announce Exclusive United States Distribution Agreement with, and Minority Investment in, ChemoMouthpiece, LLC FORT WORTH, TX, Sept. 11, 2024 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (NASDAQ: SMTI), a medical technology company focused on improving clinical outcomes and reducing healthcare expenditures in the surgical, chronic wound and skincare markets, and InfuSystem, Inc. (“InfuSystem”), the operational subsidiary of Sanara’s joint venture partner InfuSystem Holdings, Inc., announced today the execution of an InfuSystem to Participate in Lake Street’s 8th Annual Best Ideas Growth (BIG8) Conference September 12, 2024 ROCHESTER HILLS, Mich., September 04, 2024--InfuSystem to Participate in Lake Street’s 8th Annual Best Ideas Growth (BIG8) Conference September 12, 2024 Smith & Nephew (SNN) Partners InfuSystem for Renasys Edge Smith & Nephew (SNN) inks a three-year agreement with InfuSystem (INFU) to distribute its RENASYS EDGE negative pressure wound therapy system. InfuSystem Reports Second Quarter 2024 Financial Results ROCHESTER HILLS, Mich., August 08, 2024--InfuSystem Reports Second Quarter 2024 Financial Results InfuSystem Announces Distribution Agreement with Smith+Nephew for Negative Pressure Wound Therapy System and First Shipment of NPWT Systems ROCHESTER HILLS, Mich., August 06, 2024--InfuSystem Announces Distribution Agreement with Smith+Nephew for Negative Pressure Wound Therapy System and First Shipment of NPWT Systems InfuSystem to Report Second Quarter 2024 Financial Results on August 8, 2024 ROCHESTER HILLS, Mich., August 02, 2024--InfuSystem to Report Second Quarter 2024 Financial Results on August 8, 2024 Why Is Minerva Advisors Bullish on InfuSystem Holdings, Inc. (INFU) Right Now? We recently compiled a list of the 10 Best Small-Cap Stocks to Buy Now According to Minerva Advisors. In this article, we are going to take a look at where InfuSystem Holdings, Inc. (NYSE:INFU) stands against the other small-cap stocks. Established in the fourth quarter of 2002, Minerva Advisors, based in Pennsylvania, is an activist […] Sidoti Events, LLC's Virtual June Small-Cap Conference NEW YORK, NY / ACCESSWIRE / June 11, 2024 / Sidoti Events, LLC, an affiliate of Sidoti & Company, LLC, has released the presentation schedule and weblinks for its two-day June Small-Cap Conference taking place Wednesday and Thursday, June 12-13, 2024. ... InfuSystem to Present at Sidoti Small Cap Conference on June 12, 2024 ROCHESTER HILLS, Mich., June 04, 2024--InfuSystem to Present at Sidoti Small Cap Conference on June 12, 2024 Performance Overview Trailing total returns as of 1/10/2025, which may include dividends or other distributions. Benchmark is S&P 500 Return INFU S&P 500 YTD -5.75% -1.35% 1-Year -23.37% +22.51% 3-Year -52.19% +24.59%